432 related articles for article (PubMed ID: 27801764)
1. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
2. Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review.
Lee S; Sahasrabuddhe VV; Mendoza-Cervantes D; Zhao R; Duggan MA
Int J Gynecol Pathol; 2018 Mar; 37(2):128-140. PubMed ID: 28582347
[TBL] [Abstract][Full Text] [Related]
3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
5. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
6. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
7. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
[TBL] [Abstract][Full Text] [Related]
8. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
9. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
10. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
11. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
12. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
[TBL] [Abstract][Full Text] [Related]
13. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
14. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
[TBL] [Abstract][Full Text] [Related]
16. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
17. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
Goyal A; Yang B
Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
[TBL] [Abstract][Full Text] [Related]
18. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
20. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]